Study ID: FpS-AS-202 | 2010-023601-35
Study Title
- A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Teva Identifier
- FpS-AS-202 | 2010-023601-35
ClinicalTrials.gov Identifier
- NCT01576718
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Fp MDPI | Other: Placebo MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 04/01/2012 - 10/01/2013
Phase
- Phase 2
Study Type
Interventional
